Spiros A Vlahopoulos (Spiros Vlahopoulos)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 19

Top Venues

Cancers

International journal of molecular sciences

Molecular biology reports

The Journal of biological chemistry

National and Kapodistrian University of Athens - Faculty of Medicine

University of Texas (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National and Kapodistrian University of Athens - Faculty of Medicine

Greece

Biologist / Researcher :: Horemeio Research Insitute, Aghia Sophia Childrens' Hospital

National Hellenic Research Foundation

Greece

Collaborating Biologist :: Biomedical Applications

Baylor College of Medicine Jan 01 2000 - Aug 31 2002

United States

Senior Research Associate :: Molecular Cardiology

Education History

University of Texas

United States

PHD :: Human Biological Chemistry and Genetics

Publications

Lokman Varışlı, Spiros A Vlahopoulos
Epithelial-Mesenchymal Transition in Acute Leukemias. International journal of molecular sciences 25 (4) (2024)
Spiros A Vlahopoulos
Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin. International journal of molecular sciences 25 (16) (2024)
Lokman Varışlı, Spiros A Vlahopoulos
Epithelial-Mesenchymal Transition in Acute Leukemias. International journal of molecular sciences 25 (4) (2024)
Lokman Varışlı, Spiros A Vlahopoulos
Epithelial-Mesenchymal Transition in Acute Leukemias. International journal of molecular sciences 25 (4) (2024)
Spiros A Vlahopoulos
Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin. International journal of molecular sciences 25 (16) (2024)
Spiros A Vlahopoulos, Lang Pan, Lokman Varışlı, Garrett M Dancik, Theodoros Karantanos, Istvan Boldogh
OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer. Cancers 16 (1) (2023)
Venturina Stagni, Archontia Kaminari, Claudia Contadini, Daniela Barilà, Rosario Luigi Sessa, Zili Sideratou, Spiros A Vlahopoulos, Dimitris Tsiourvas
A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres. Cancers 15 (5) (2023)
Lokman Varışlı, Garrett M Dancik, Veysel Tolan, Spiros A Vlahopoulos
Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target. Cancers 15 (21) (2023)
Garrett M Dancik, Lokman Varışlı, Veysel Tolan, Spiros A Vlahopoulos
Aldehyde Dehydrogenase Genes as Prospective Actionable Targets in Acute Myeloid Leukemia. Genes 14 (9) (2023)
Spiros A Vlahopoulos, Lang Pan, Lokman Varışlı, Garrett M Dancik, Theodoros Karantanos, Istvan Boldogh
OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer. Cancers 16 (1) (2023)
Spiros A Vlahopoulos, Lang Pan, Lokman Varışlı, Garrett M Dancik, Theodoros Karantanos, Istvan Boldogh
OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer. Cancers 16 (1) (2023)
Venturina Stagni, Archontia Kaminari, Claudia Contadini, Daniela Barilà, Rosario Luigi Sessa, Zili Sideratou, Spiros A Vlahopoulos, Dimitris Tsiourvas
A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres. Cancers 15 (5) (2023)
Garrett M Dancik, Lokman Varışlı, Spiros A Vlahopoulos
The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia. International journal of molecular sciences 24 (11) (2023)
Garrett M Dancik, Ioannis F Voutsas, Spiros A Vlahopoulos
Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia. Molecular biology reports 49 (4) (2022)
Spiros A Vlahopoulos, Ke Wang, Yaoyao Xue, Xu Zheng, Istvan Boldogh, Lang Pan
Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections. Cells 10 (11) (2021)
George I Lambrou, Kyriaki Hatziagapiou, Spiros A Vlahopoulos
Inflammation and tissue homeostasis: the NF-κB system in physiology and malignant progression. Molecular biology reports 47 (5) (2020)
Lokman Varışlı, Osman Cen, Spiros A Vlahopoulos
Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways. Immunology 159 (3) (2019)
Katerina N Panagiotaki, Zili Sideratou, Spiros A Vlahopoulos, Maria Paravatou-Petsotas, Michael Zachariadis, Nikolas Khoury, Vassilis Zoumpourlis, Dimitris Tsiourvas
A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity. Pharmaceuticals (Basel, Switzerland) 10 (4) (2017)
Lang Pan, Bing Zhu, Wenjing Hao, Xianlu Zeng, Spiros A Vlahopoulos, Tapas K Hazra, Muralidhar L Hegde, Zsolt Radak, Attila Bacsi, Allan R Brasier, Xueqing Ba, Istvan Boldogh
Oxidized Guanine Base Lesions Function in 8-Oxoguanine DNA Glycosylase-1-mediated Epigenetic Regulation of Nuclear Factor κB-driven Gene Expression. The Journal of biological chemistry 291 (49) (2016)

Spiros A Vlahopoulos.css-eqlu8i{font-size:small;padding-left:4px;} (Spiros Vlahopoulos)

Publication Activity (10 Years)

Top Topics

Top Venues

Spiros A Vlahopoulos (Spiros Vlahopoulos)